Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease

NCT02792257 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02792257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02792257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
March 1, 2017
Completion date
May 31, 2024
Enrollment
84 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease